JPS58208232A - オルガノホスホネ−トおよびステロイドを含有する抗炎症ならびに抗リウマチ組成物 - Google Patents

オルガノホスホネ−トおよびステロイドを含有する抗炎症ならびに抗リウマチ組成物

Info

Publication number
JPS58208232A
JPS58208232A JP58033685A JP3368583A JPS58208232A JP S58208232 A JPS58208232 A JP S58208232A JP 58033685 A JP58033685 A JP 58033685A JP 3368583 A JP3368583 A JP 3368583A JP S58208232 A JPS58208232 A JP S58208232A
Authority
JP
Japan
Prior art keywords
steroid
compound
organophosphonate
prednisolone
diphosphonic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP58033685A
Other languages
English (en)
Japanese (ja)
Inventor
ベニ−・リ−・ベイカ−
ロ−レンス・フロ−ラ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Procter and Gamble Co
Original Assignee
Procter and Gamble Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter and Gamble Co filed Critical Procter and Gamble Co
Publication of JPS58208232A publication Critical patent/JPS58208232A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP58033685A 1982-03-01 1983-03-01 オルガノホスホネ−トおよびステロイドを含有する抗炎症ならびに抗リウマチ組成物 Pending JPS58208232A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US35312082A 1982-03-01 1982-03-01
US353120 1982-03-01

Publications (1)

Publication Number Publication Date
JPS58208232A true JPS58208232A (ja) 1983-12-03

Family

ID=23387842

Family Applications (1)

Application Number Title Priority Date Filing Date
JP58033685A Pending JPS58208232A (ja) 1982-03-01 1983-03-01 オルガノホスホネ−トおよびステロイドを含有する抗炎症ならびに抗リウマチ組成物

Country Status (4)

Country Link
EP (1) EP0088462A3 (fr)
JP (1) JPS58208232A (fr)
AU (1) AU1190983A (fr)
ZA (1) ZA831373B (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04352795A (ja) * 1991-01-22 1992-12-07 Merck & Co Inc 新規な骨作用剤

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1187828B (it) * 1985-05-24 1987-12-23 Gentili Ist Spa Composizione farmaceutica a base di difosfonati per il trattamento dell aretrosi
US5407926A (en) * 1987-12-29 1995-04-18 Alcon Laboratories, Inc. Ophthalmic composition
CA2064478C (fr) * 1989-08-28 2002-07-02 Abbot F. Clark Composition ophthalmique
US5183815A (en) * 1991-01-22 1993-02-02 Merck & Co., Inc. Bone acting agents
CA2101275C (fr) 1991-02-26 1998-08-04 Jocelyn Elaine Mcosker Methodes de traitement de l'osteoporose
FR2683527A1 (fr) * 1991-11-12 1993-05-14 Bretagne Occidentale Universit Prodrogues gem-bisphosphonates de sterouides derives de la cortisone.
EP0550385A1 (fr) * 1991-12-19 1993-07-07 Ciba-Geigy Ag Compositions pharmaceutiques orales contenant des dérivés d'acide méthane-diphosphonique et des éthers 18-couronne-6
JP2746041B2 (ja) * 1992-02-14 1998-04-28 三菱化学株式会社 新規なステロイド誘導体
US5652227A (en) * 1995-01-30 1997-07-29 Teronen; Olli Pekka Inhibition of the degradation of connective tissue matrix protein components in mammals

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3639585A (en) * 1968-03-29 1972-02-01 Res Inst Medicine Chem Method of preventing corticosteroid-induced adverse effects on bon and compositions useful in said method
US4275059A (en) * 1977-03-28 1981-06-23 The Procter & Gamble Company Salicylate anti-inflammatory composition
US4216212A (en) * 1978-06-08 1980-08-05 The Procter & Gamble Company Pyrazolidine anti-inflammatory composition and methods of use
US4264582A (en) * 1978-07-31 1981-04-28 The Procter & Gamble Company Isobutylphenylacetate anti-inflammatory composition
US4282214A (en) * 1978-07-31 1981-08-04 The Procter & Gamble Company Phenylacetate anti-inflammatory composition

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04352795A (ja) * 1991-01-22 1992-12-07 Merck & Co Inc 新規な骨作用剤

Also Published As

Publication number Publication date
AU1190983A (en) 1983-09-08
EP0088462A3 (fr) 1984-06-06
EP0088462A2 (fr) 1983-09-14
ZA831373B (en) 1983-12-28

Similar Documents

Publication Publication Date Title
Albright et al. A comparison of the effects of AT 10 (dihydrotachysterol) and vitamin D on calcium and phosphorus metabolism in hypoparathyroidism
US3683080A (en) Compositions for inhibiting anomalous deposition and mobilization of calcium phosphate in animal tissue
DE69125714T2 (de) Zusammensetzung für die behandlung des humanen prostata adenokarzinom
DE69737066T2 (de) Verwendung von aktivem Vitamin D analog zur Behandlung von Prostataerkrankungen
US4330530A (en) Anti-arthritic compositions and method using gold salts and organophosphonates
US4275059A (en) Salicylate anti-inflammatory composition
JPS58208232A (ja) オルガノホスホネ−トおよびステロイドを含有する抗炎症ならびに抗リウマチ組成物
DE2360797C2 (de) Pharmazeutische Präparate
US4634691A (en) Method for inhibiting tumor metastasis
US3662066A (en) Compositions for inhibiting anomalous deposition and mobilization of calcium phosphate in animal tissue
GB1588284A (en) Anti-inflammatory drug based on phosphonates plus other anti-inflammatories
US4234645A (en) Pharmaceutical composition
WO1989007453A1 (fr) Medicaments comprenant une combinaison d'agents cytostatiques ou d'agents hormonaux therapeutiques et de derives de phosphone
US4252797A (en) Corticosteroid calcium compositions and treatment of rheumatic diseases therewith
Azarnoff et al. Incorporation of acetate-1-C14 into cholesterol by human intracranial tumors in vitro
US4264582A (en) Isobutylphenylacetate anti-inflammatory composition
US4216212A (en) Pyrazolidine anti-inflammatory composition and methods of use
US4282214A (en) Phenylacetate anti-inflammatory composition
AU722364B2 (en) Therapeutic agents for asthma
Holgate Reflections on the mechanism (s) of action of sodium cromoglycate (Intal) and the role of mast cells in asthma
Bauer et al. Studies on the mode of action of irradiated ergosterol: IV. In hypoparathyroidism
US3639585A (en) Method of preventing corticosteroid-induced adverse effects on bon and compositions useful in said method
DE2261571A1 (de) Arzneipraeparate mit cholesterinspiegelsenkender wirkung
JPS5874619A (ja) リポソ−ム及びその製法
Husby et al. Comparative double-blind trial of intra-articular injections of two long-acting forms of betamethasone